Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP566761.RAfnGW3igxgFCcygCgfyVqi_8JZbm1ABqSts50Cy5V5pw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP566761.RAfnGW3igxgFCcygCgfyVqi_8JZbm1ABqSts50Cy5V5pw130_assertion type Assertion NP566761.RAfnGW3igxgFCcygCgfyVqi_8JZbm1ABqSts50Cy5V5pw130_head.
- NP566761.RAfnGW3igxgFCcygCgfyVqi_8JZbm1ABqSts50Cy5V5pw130_assertion description "[TCR alpha CDR3 spectratyping showed preferential usage of certain TRAV genes in the PBMCs and TILs of all patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566761.RAfnGW3igxgFCcygCgfyVqi_8JZbm1ABqSts50Cy5V5pw130_provenance.
- NP566761.RAfnGW3igxgFCcygCgfyVqi_8JZbm1ABqSts50Cy5V5pw130_assertion evidence source_evidence_literature NP566761.RAfnGW3igxgFCcygCgfyVqi_8JZbm1ABqSts50Cy5V5pw130_provenance.
- NP566761.RAfnGW3igxgFCcygCgfyVqi_8JZbm1ABqSts50Cy5V5pw130_assertion SIO_000772 22862170 NP566761.RAfnGW3igxgFCcygCgfyVqi_8JZbm1ABqSts50Cy5V5pw130_provenance.
- NP566761.RAfnGW3igxgFCcygCgfyVqi_8JZbm1ABqSts50Cy5V5pw130_assertion wasDerivedFrom befree-20140225 NP566761.RAfnGW3igxgFCcygCgfyVqi_8JZbm1ABqSts50Cy5V5pw130_provenance.
- NP566761.RAfnGW3igxgFCcygCgfyVqi_8JZbm1ABqSts50Cy5V5pw130_assertion wasGeneratedBy ECO_0000203 NP566761.RAfnGW3igxgFCcygCgfyVqi_8JZbm1ABqSts50Cy5V5pw130_provenance.